Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Ogden currently holds 296,948 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Ogden has been a net seller of CTMX stock. They have purchased $0 and sold $136.5K worth of shares.
Christopher Ogden's most recent insider trade was on Mar 17, 2026, when they sold 19,323 shares at $6.42 per share.
Christopher Ogden serves as Executive at CytomX Therapeutics, Inc. (CTMX). They have executed 16 insider transactions totaling $136.5K over their tenure at the company.
Christopher Ogden holds the position of Executive at CytomX Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Christopher Ogden has shown a selling trading pattern, with $0 in total purchases and $136.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Ogden was on Mar 17, 2026, when they sold $124.1K worth of CTMX shares. This transaction involved 19,323 shares at $6.42 per share.
Christopher Ogden currently owns 296,948 shares of CytomX Therapeutics, Inc. (CTMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Ogden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Ogden has 16 Form 4 filings on record as an insider at CytomX Therapeutics, Inc..
Set alerts for Christopher Ogden and 40,000+ other insiders.